Cargando…
Systemic treatment in EGFR-ALK NSCLC patients: second line therapy and beyond
Lung cancer is the most frequently diagnosed cancer and a leading cause of cancer mortality worldwide, with adenocarcinoma being the most common histological subtype. Deeper understanding of the pathobiology of non-small cell lung cancer (NSCLC) has led to the development of small molecules that tar...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Chinese Anti-Cancer Association
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197428/ https://www.ncbi.nlm.nih.gov/pubmed/25364578 http://dx.doi.org/10.7497/j.issn.2095-3941.2014.03.003 |